Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

More News From fortuneweek.com

Brazil great Kaka retiring from soccer at age 35

Dec 17, 2017

Former Ballon d'Or winner Kaka says he is retiring from soccer at age 35. Kaka, who played for Brazil, AC Milan and Real Madrid, told Brazil's Globo TV on Sunday that "my last word is that the cycle of my career as a player ends here." "I needed time to think and take a decision calmly," Kaka said. "I have arrived to the conclusion that now is the moment to finish my career as a professional player." A graceful midfielder, Kaka won 92 caps for Brazil, scoring 29 goals and featuring at three World Cups. He was part of the...

The Latest: Vikings crushing Bengals 24-0 at halftime

Dec 17, 2017

The Latest on the NFL's 15th Sunday of the regular season (all times Eastern): 2:45 p.m. The Minnesota Vikings are cruising toward their second NFC North title in three years. They're leading the Cincinnati Bengals 24-0 at halftime, needing a win to clinch the division crown. The Vikings have allowed only one first down and 42 total yards to the Bengals. Cincinnati began the game missing five starters on defense to injuries. They lost a sixth when free safety George Iloka hurt his shoulder in the first quarter. As if the game wasn't bad enough, the Bengals are also dealing...

AC Milan crisis deepens with 3-0 defeat at Verona in Serie A

Dec 17, 2017

MILAN — AC Milan's crisis deepened as it was humiliated 3-0 at struggling Hellas Verona in Serie A on Sunday. Elsewhere, Juventus won 3-0 at Bologna to leapfrog Inter Milan into second spot, a point behind Serie A leader Napoli. "We have to apologize and understand why these things happen. We were embarrassing," Milan coach Gennaro Gattuso said. "I think that until Verona doubled its lead, we did well and even deserved to score. Then, as often happens, we collapsed after the first moment of difficulty. "We don't manage to react or if we do, we seem confused and messy....

Bailey stars but Leverkusen held 4-4, Hertha beats Leipzig

Dec 17, 2017

BERLIN — Jamaica striker Leon Bailey scored twice as a substitute but Bayer Leverkusen failed to hang on as Hannover grabbed a 4-4 draw in the Bundesliga on Sunday. Bailey, who came on at the break, needed only two minutes to equalize after Hannover had gone 3-2 ahead, and he scored again 20 minutes later to put Leverkusen 4-3 in front. But the 20-year-old missed another chance to complete a hat trick and Julian Korb scored late for Hannover to draw. "I had a third chance, and I just know if I had taken that chance it would have been...

Report: NFL owner made inappropriate sexual, racist remarks

Dec 17, 2017

CHARLOTTE, N.C. — The NFL and the Carolina Panthers declined comment on a report Sunday that at least four former Panthers employees received monetary settlements due to inappropriate workplace comments and conduct by owner Jerry Richardson. The Sports Illustrated report cites unnamed sources who said Richardson made sexually suggestive comments to women and on at least one occasion directed a racial slur at an African-American Panthers scout. The report states that the settlements came with non-disclosure requirements forbidding the parties from discussing the details. The NFL on Sunday said it has taken over the investigation of allegations of workplace misconduct...